Skip to content
healthcare.dev
Get a free key

Rybrevant

NDC 57894-501, amivantamab-vmjw, injection, from Janssen Biotech, Inc..

Product NDC
57894-501
Status
Listed
Labeler
Janssen Biotech, Inc.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761210
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/57894-501 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AMIVANTAMAB350 mg/1
Package NDCNDC-11Package
57894-501-01578940501011 VIAL, SINGLE-USE in 1 CARTON (57894-501-01) / 1 INJECTION in 1 VIAL, SINGLE-USE (57894-501-00)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1466c070-9f97-4fa4-a955-6a6b59981fb8

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=57894-501

Use it

Look up 57894-501 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/57894-501 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 57894-501. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.